ADAM-1 (Recombinant)

Recombinant Protein · expressed in HEK293
Citation tracking pending
Recombinant human ADAM-1 (Fertilin subunit alpha-a, UniProt Q60813) expressed in HEK293 cells. Suited for sperm-egg fusion research, metalloproteinase inhibitor assays, and antibody validation studies.
Expression system
HEK293
Cat. #
REC-ADAM1

In stock

SKU
REC-ADAM1
$498.00

Target Overview

ADAM-1 (Disintegrin and metalloproteinase domain-containing protein 1a; UniProt Q60813), encoded by the gene Adam1a, is a membrane-associated metalloproteinase of the ADAM (A Disintegrin And Metalloproteinase) family. The full-length protein spans 791 amino acids and carries both a disintegrin domain and a metalloproteinase domain, structural features shared across the ADAM family that underpin cell-surface shedding, adhesion, and membrane fusion events. ADAM-1 is best characterised as Fertilin subunit alpha-a, where it forms a heterodimeric complex with Fertilin subunit beta (ADAM-2) on the sperm surface and is implicated in sperm-egg membrane fusion and zona pellucida binding. This recombinant is produced in HEK293 mammalian cells, an expression system that supports the N-linked glycosylation and disulfide-bond formation characteristic of native ADAM family members — factors that can be critical for maintaining the disintegrin domain's integrin-binding conformation. Species reactivity is validated for human and predicted for mouse and rat based on sequence homology. Researchers use this reagent in several contexts: as a positive control antigen for Western blot and immunohistochemistry (IHC) antibody validation; as a defined substrate or binding partner in cell-free sperm-egg adhesion assays; and as a tool protein for characterising metalloproteinase inhibitor potency under conditions that approximate the native glycoprotein. Investigators requiring a matched immunological reagent for co-validation can pair this recombinant with the Triple Point Biologics ADAM-1 antibody (SKU: RP-ADAM1), which has been validated for Western blot against this target.

Background

ADAM-1 (Fertilin subunit alpha-a) is a member of the ADAM metalloproteinase superfamily, a group of type I transmembrane proteins characterised by a reprolysin-type metalloproteinase domain, a disintegrin domain, a cysteine-rich region, and an EGF-like domain. Within this family, ADAM-1 is most closely studied in the context of male reproductive biology, where it partners with ADAM-2 (Fertilin subunit beta) to form the Fertilin heterodimer on the sperm plasma membrane. This complex has been investigated for its roles in sperm migration through the female reproductive tract, binding to the egg's zona pellucida, and participation in sperm-egg plasma membrane fusion — making it a well-defined research target in reproductive cell biology. Published research has continued to refine the functional picture of ADAM-1 and its binding partners. Favier et al. (2025) demonstrated that a Fertilin-derived peptide reduced embryo resorption and improved live birth rates in a mouse model, illustrating how recombinant Fertilin-domain tools can be used to dissect peptide-level functional activity in reproductive outcome studies. Earlier work by Gundogan et al. (2022) examined Fertilin beta protein distribution in the context of male infertility, providing histological and biochemical data that researchers have used to contextualise ADAM family expression patterns. Beyond reproduction, ADAM family biology intersects with immunology and oncology research. Dervovic et al. (2023) employed in vivo CRISPR screens in lung cancer models to identify Adam2 — a close paralogue of ADAM-1 — as a regulator of immune therapy response, underscoring the broader relevance of ADAM-family recombinant tools for immuno-oncology mechanistic studies. In male infertility research, Ghodrati et al. (2026) combined in silico and experimental approaches to characterise miR-34a, miR-449, and ADAM2/ADAM7 expression as candidate biomarkers, a framework in which recombinant ADAM-family proteins serve as calibration standards and binding controls. Similarly, Li et al. (2024) characterised Spem2 as a testis-enriched protein required for spermiogenesis, placing ADAM-1's sperm surface role in a broader network of testicular proteins whose interactions can be probed using defined recombinant reagents. Collectively, the published literature positions recombinant ADAM-1 as a useful tool protein for in vitro adhesion and fusion assays, inhibitor potency measurements against the metalloproteinase domain, and as an antigen standard in studies characterising antibodies raised against ADAM-family targets. Triple Point Biologics has produced proteinase and inhibitor antibodies and recombinant reagents since 1994; this HEK293-expressed ADAM-1 is produced under consistent lot-to-lot protocols to support reproducibility across experimental cohorts.

Applications

  • Sperm-egg adhesion and membrane fusion assays using recombinant Fertilin alpha-a as a defined binding partner
  • Metalloproteinase inhibitor IC50 determination against the ADAM-1 disintegrin/metalloproteinase domain
  • Western blot positive control antigen for anti-ADAM-1 antibody validation (pairs with Triple Point Biologics SKU: RP-ADAM1)
  • Immunohistochemistry (IHC) antibody validation standard using HEK293-expressed ADAM-1
  • Zona pellucida binding competition assays to characterise integrin-ligand interactions mediated by the disintegrin domain
  • Recombinant antigen for ELISA standard curve generation in ADAM-1 quantification studies
  • Protein-protein interaction studies characterising ADAM-1/ADAM-2 heterodimer assembly in cell-free systems
  • Calibration standard for mass spectrometry-based quantification of ADAM-1 in reproductive tissue proteomics

References

  1. Favier S et al. Fertilin peptide decreases embryo resorption and improves live birth rate in mouse. F S Sci. 2025. doi:10.1016/j.xfss.2025.08.001. PMID: 40784371.
  2. Ghodrati F et al. Exploring miR-34a, miR-449, and ADAM2/ADAM7 Expressions as Potential Biomarkers in Male Infertility: A Combined In Silico and Experimental Approach. Biochem Genet. 2026. doi:10.1007/s10528-025-11050-1. PMID: 39928278.
  3. Li C et al. Spem2, a novel testis-enriched gene, is required for spermiogenesis and fertilization in mice. Cell Mol Life Sci. 2024. doi:10.1007/s00018-024-05147-w. PMID: 38421455.
  4. Dervovic D et al. In vivo CRISPR screens reveal Serpinb9 and Adam2 as regulators of immune therapy response in lung cancer. Nat Commun. 2023. doi:10.1038/s41467-023-38841-7. PMID: 37258521.
  5. Gundogan GI et al. Is there a relationship between infertility and fertilin β protein distribution? Rev Int Androl. 2022. doi:10.1016/j.androl.2021.04.003. PMID: 35933293.

Additional Specifications

Storage Buffer 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl₂, 10% glycerol
Endotoxin Level <0.1 EU/µg by LAL
Purity (%) >90% by SDS-PAGE
Expression System HEK293
Subcellular Localization Type I transmembrane; cell surface; Golgi → endosomes

Frequently Asked Questions

What molecular weight band should I expect for recombinant ADAM-1 on SDS-PAGE or Western blot?

The full-length ADAM-1 (UniProt Q60813) has a predicted molecular weight of ~90 kDa from its 791-amino-acid sequence, but HEK293-expressed recombinant ADAM-1 typically runs at 95–110 kDa under reducing SDS-PAGE conditions due to N-linked glycosylation. Under non-reducing conditions, disulfide-linked species may appear at higher apparent masses. Purity is confirmed at >95% by SDS-PAGE before release. If you are using the matched antibody RP-ADAM1 for detection, the glycosylated band in this range is the expected positive-control signal.

Is this recombinant ADAM-1 the full-length protein or a processed/cleaved form like the mature ectodomain?

This recombinant represents the mature, processed form of ADAM-1a (Fertilin alpha-a), with the prodomain removed — consistent with the endogenous processing that occurs during sperm maturation. The prodomain acts as an autoinhibitory cysteine-switch; its removal yields the active metalloproteinase and disintegrin domains. The expressed construct retains the disintegrin and metalloproteinase domains critical for integrin binding and zona pellucida interactions. The exact boundaries of the expressed fragment are noted in the datasheet; confirm these match your experimental epitope of interest before proceeding.

What substrates can I use to measure ADAM-1 metalloproteinase activity in a fluorescence assay?

ADAM-1 is a zinc-dependent metalloproteinase; fluorogenic peptide substrates based on the Mca/Dnp quenched-peptide format used broadly for ADAM family members — such as Mca-PLAQAV-Dpa-NH2 or similar sequences — are a reasonable starting point. ADAM-1's in vivo substrates are less well-characterized than ADAM-10 or ADAM-17, so substrate selection should be validated empirically. Run activity assays in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM CaCl2 (matching the storage buffer) to avoid buffer-exchange losses and maintain zinc/calcium cofactor requirements.

What is a recommended starting concentration of recombinant ADAM-1 for an in vitro metalloproteinase activity assay?

A starting range of 50–200 nM recombinant ADAM-1 is appropriate for initial fluorogenic substrate assays, with substrate concentrations titrated from 5–100 µM to bracket Km. Because ADAM-1's specific activity toward synthetic peptide substrates has not been as thoroughly benchmarked as ADAM-10 or ADAM-17, include a positive-control metalloproteinase of known activity in the same assay run. Dilute from the stock using assay buffer containing 5 mM CaCl2; omitting calcium can substantially reduce metalloproteinase activity. Avoid BSA-containing diluents unless empirically validated, as BSA can compete in some fluorescence formats.

How should I optimize buffer conditions for recombinant ADAM-1 activity and avoid loss of activity during dilution?

The storage buffer — 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl2 — is formulated to stabilize metalloproteinase activity during freeze-thaw. When diluting into assay buffer, maintain CaCl2 at ≥1 mM and keep pH between 7.2 and 7.8; activity drops significantly below pH 6.5. Glycerol can be reduced to 1–2% in the working dilution without major stability impact. EDTA and EGTA are strong inhibitors — even trace contamination from EDTA-containing buffers will chelate zinc and abolish activity. Pre-warm working dilutions to 37°C before adding substrate.

Can I use recombinant ADAM-1 as a positive control for Western blot with the RP-ADAM1 rabbit polyclonal antibody?

Yes — this is a validated pairing. The matched rabbit polyclonal antibody RP-ADAM1 (/anti-adam-1-rabbit-polyclonal-antibody) was raised against ADAM-1 and is guaranteed compatible for Western blot positive-control experiments. Load 50–200 ng of recombinant ADAM-1 per lane alongside your experimental lysates; the antibody should detect the glycosylated band at 95–110 kDa under reducing conditions. This pairing is particularly useful for antibody validation workflows where a defined, high-purity recombinant antigen is needed to confirm specificity before committing to tissue or cell lysate samples.

How much recombinant ADAM-1 should I load for Western blot when validating the RP-ADAM1 antibody?

For a standard Western blot validation lane, load 100 ng of recombinant ADAM-1 as a starting point alongside a titration of 25, 50, and 100 ng to establish the linear detection range with RP-ADAM1. Run under reducing conditions (β-mercaptoethanol or DTT) to resolve the monomer at 95–110 kDa. If signal is saturating at 100 ng, step down to 25–50 ng. Because purity is >95% by SDS-PAGE, the dominant band reflects ADAM-1 and not contaminating proteins, giving a clean positive-control lane for antibody specificity documentation.

What is the shelf life of recombinant ADAM-1 and how should I handle aliquots to preserve activity?

Recombinant ADAM-1 is stable for up to 12 months at -20°C in single-use aliquots in its formulated buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 5 mM CaCl2). Avoid repeated freeze-thaw cycles — even two cycles can measurably reduce metalloproteinase activity. Upon receipt, spin briefly at 1,000 × g, aliquot into volumes matching your typical experiment, and snap-freeze in liquid nitrogen before returning to -20°C. Once thawed, use within the same working session; do not refreeze. Do not store at 4°C for more than 48 hours, as protease autolysis can occur over time.

Validation imagery coming soon

Western blot validation figures for REC-ADAM1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →